Lyophilization Services for Biopharmaceuticals Global Report 2024, Featuring Profiles of Strides Pharma Science, Baxter, Catalent Pharma Solutions, W. L. Gore & Associates and Emergent BioSolutions
09 avr. 2024 11h28 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Lyophilization Services for Biopharmaceuticals Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The...
US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030: A $1.28 Trillion Opportunity, Driven by the Rising Adoption of AI-based Tools for Drug Discovery
27 mars 2024 08h34 HE
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product...
Global Bevacizumab Biosimilars Market Outlook 2024-2028 & 2033 Featuring Cipla, Reliance Lifesciences, Genentech, Fujifilm Kyowa Kirin Biologics, and Pfizer
06 mars 2024 07h30 HE
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Bevacizumab Biosimilars Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The bevacizumab biosimilars market has...
Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
23 févr. 2024 13h50 HE
|
Spherix Global Insights
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...
Aflibercept (Eylea) Biosimilars Pipeline Review 2024: Patents are Due to Run out from 2023 to 2032
23 févr. 2024 07h32 HE
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Aflibercept (Eylea) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides basic information on...
Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review 2024
23 févr. 2024 07h31 HE
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Eculizumab (Soliris) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
Biosimilar Interleukins ( IL-17, IL-23, IL-1, IL-5, IL-6 ) Global Market Report 2024 - Robust CAGR of 40% Predicted by 2028
13 févr. 2024 11h46 HE
|
Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Interleukins Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest comprehensive research on the...
Global Biosimilars and Biologics Market Surges: $46.11 Billion Market Forecast for 2028 - Industry Trends and Strategic Analysis
02 févr. 2024 10h43 HE
|
Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilars and Biologics Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis"...
Biosimilars Market Poised for Substantial Growth by 2031, Driven by Rising Chronic Disease Prevalence
29 janv. 2024 12h36 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user,...
Biosimilar Insulin Market Global Industry Analysis - Market Set to Surge, Spearheaded by High Demand in APAC and Cost-Effective Innovations
29 janv. 2024 12h24 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Biosimilar Insulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...